The rise of copyright’s blockbuster initially drove a period of growth for major pharmaceutical companies, but recent developments present a murky scenario for shareholders. Off-patent alternatives are eroding https://estelleavqg353448.blogozz.com/39993737/viagra-and-big-pharma-a-volatile-play